BellaSeno GmbH, an ISO 13485-certified clinical-stage medtech company developing absorbable scaffolds using additiv...
Monash Institute of Pharmaceutical Sciences (MIPS) in Australia is leading a collaboration of academic and industry part...
The research team, led by Bioresource Processing Institute of Australia (BioPRIA) and Monash University’...
In early June 2020, Australia’s Department of Health offered $13.6 million to support 10 clinical trials rese...
Dr. Harsh Vardhan, Union Minister for Health and Family Welfare, Government of India had a digital interaction with his ...
Australia based CLINUVEL Pharmaceuticals, has announced PRÉNUMBRA®, the Company’s second afamelanotide ...
Australia based Luina Bio is pleased to announce they have been selected to partner with XING Technologies (Brisbane) to...
Carromex, a mathematical research-based innovation company based in Australia, unveiled a new cloud-based pharmaceu...
The leading Australian CRO for biotechs, Avance Clinical, accepted the prestigious Frost & Sullivan 2020 Asia-Pacifi...
Australia based CSL Limited's part, CSL Behring has announced that the first patient has been enrolled in its ...
Melbourne-based Affinity Biosciences Pty Ltd (Affinity), a privately held company focused on antibody discovery for canc...
Australia’s commitment to support the health and wellbeing of the Pacific Island neighbours remains steadfast, wit...
The Australian Government is investing $19 million in transformative medical research projects using game-changing appli...
Alterity Therapeutics announced that it has received guidance from the US Food and Drug Administration (FDA) in relation...
US based Synchron Inc., a neurovascular bioelectronic medicine company, has announced that the University of Melbou...
The Mitra® microsampling device from US company Neoteryx has been registered as a Class I in vitro diagnostic (IVD) ...
The Australian government, together with the National Heart Foundation, is announcing a further $12 million for research...
The Australian Government is investing over $5.7 million to further develop traumatic brain injury research, aimed at im...
